<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37700355</PMID><DateCompleted><Year>2023</Year><Month>09</Month><Day>14</Day></DateCompleted><DateRevised><Year>2023</Year><Month>11</Month><Day>19</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1750-1172</ISSN><JournalIssue CitedMedium="Internet"><Volume>18</Volume><Issue>1</Issue><PubDate><Year>2023</Year><Month>Sep</Month><Day>12</Day></PubDate></JournalIssue><Title>Orphanet journal of rare diseases</Title><ISOAbbreviation>Orphanet J Rare Dis</ISOAbbreviation></Journal><ArticleTitle>Symptoms of SARS-CoV-2 infection and vaccine status of sixty-seven adult patients affected by inherited metabolic diseases: a phone survey.</ArticleTitle><Pagination><StartPage>286</StartPage><MedlinePgn>286</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">286</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s13023-023-02905-0</ELocationID><Abstract><AbstractText Label="BACKGROUND">The Covid pandemic seems to have had several detrimental effects on managing patients affected by inherited metabolic diseases (IMD), although published data about the impact of COVID-19 on patients suffering from IMD are very scarce. The scope of our work was to evaluate adherence to the vaccination plan, the side effects experienced by our adult IMD patients, and the symptoms of the SARS-CoV-2 infection.</AbstractText><AbstractText Label="RESULTS">Sixty-seven patients agreed to respond to a phone interview. The mean age was 36.5 (&#xb1;&#x2009;11.6 SD). Regarding the vaccination campaign, fifty-five patients (82%) joined it, of whom ten had received two doses and the remaining forty-five, three. Forty-two patients (76%) reported adverse events following vaccination, the most frequent being local reaction, fever, and asthenia, which lasted an average of two days and resolved without sequelae. Regarding SARS-CoV-2 infection, twenty-seven out of sixty-seven patients (40%) tested positive for the virus; seven of them were not vaccinated at the time of infection; on the other hand, twenty had already had at least two doses. Regarding the prevalence of long-Covid, as many as 12 patients (44%) reported symptoms that persisted after the nasopharyngeal swab tested negative and lasted an average of 81 (&#xb1;&#x2009;74 SD) days. There were no statistically significant differences in BMI of patients who contracted the infection and patients who did not (25.15 vs. 25.20, p&#x2009;=&#x2009;.861), between those who had adverse reactions to the vaccine and those who did not (24.40 vs. 25.75, p&#x2009;=&#x2009;.223), between those who had long-Covid and those who did not (25.9 vs. 27.7, p&#x2009;=&#x2009;.183). No relation was observed between metabolic inherited disease, SARS-CoV-2 infection symptoms and adverse vaccine reactions.</AbstractText><AbstractText Label="CONCLUSIONS">The data indicate that IMD patients adhered to the vaccination campaign comparably to the general Italian population. Adverse events to the vaccine were negligible. SARS-CoV-2 infection, which occurred in most cases after receiving at least two doses of the vaccine, did not cause serious symptoms and never required hospitalisation. A non-negligible share of patients suffered from long-Covid symptoms.</AbstractText><CopyrightInformation>&#xa9; 2023. Institut National de la Sant&#xe9; et de la Recherche M&#xe9;dicale (INSERM).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Brodosi</LastName><ForeName>Lucia</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0002-7735-7847</Identifier><AffiliationInfo><Affiliation>Department of Medical and Surgical Sciences, University of Bologna, Via Zamboni, 33, Bologna, 40126, Italy. lucia.brodosi2@unibo.it.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Clinical Nutriti on and Metabolism Unit, IRCCS AOUBO, Via Albertoni, 15, Bologna, 40138, Italy. lucia.brodosi2@unibo.it.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stecchi</LastName><ForeName>Michele</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Medical and Surgical Sciences, University of Bologna, Via Zamboni, 33, Bologna, 40126, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mita</LastName><ForeName>Dorina</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Medical and Surgical Sciences, University of Bologna, Via Zamboni, 33, Bologna, 40126, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Marchignoli</LastName><ForeName>Francesca</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Clinical Nutriti on and Metabolism Unit, IRCCS AOUBO, Via Albertoni, 15, Bologna, 40138, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Guarneri</LastName><ForeName>Valeria</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Department of Medical and Surgical Sciences, University of Bologna, Via Zamboni, 33, Bologna, 40126, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Agnelli</LastName><ForeName>Giulio</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Medical and Surgical Sciences, University of Bologna, Via Zamboni, 33, Bologna, 40126, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Osti</LastName><ForeName>Valentino</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Department of Public Health, Azienda USL di Bologna, Via Gramsci, 12, Bologna, 40121, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Perazza</LastName><ForeName>Federica</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Medical and Surgical Sciences, University of Bologna, Via Zamboni, 33, Bologna, 40126, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sacilotto</LastName><ForeName>Federica</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Medical and Surgical Sciences, University of Bologna, Via Zamboni, 33, Bologna, 40126, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pession</LastName><ForeName>Andrea</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Medical and Surgical Sciences, University of Bologna, Via Zamboni, 33, Bologna, 40126, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Pediatric Unit, IRCCS AOUBO, Via Albertoni, 15, Bologna, 40138, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pironi</LastName><ForeName>Loris</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Medical and Surgical Sciences, University of Bologna, Via Zamboni, 33, Bologna, 40126, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Clinical Nutriti on and Metabolism Unit, IRCCS AOUBO, Via Albertoni, 15, Bologna, 40138, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>09</Month><Day>12</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Orphanet J Rare Dis</MedlineTA><NlmUniqueID>101266602</NlmUniqueID><ISSNLinking>1750-1172</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008659" MajorTopicYN="Y">Metabolic Diseases</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018450" MajorTopicYN="N">Disease Progression</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D064420" MajorTopicYN="Y">Drug-Related Side Effects and Adverse Reactions</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Hereditary metabolic disorders</Keyword><Keyword MajorTopicYN="N">Inherited metabolic diseases</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">Vaccination</Keyword></KeywordList><CoiStatement>The authors declare that they have no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>4</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>8</Month><Day>31</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>9</Month><Day>14</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>9</Month><Day>13</Day><Hour>0</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>9</Month><Day>12</Day><Hour>23</Hour><Minute>48</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>9</Month><Day>12</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37700355</ArticleId><ArticleId IdType="pmc">PMC10496155</ArticleId><ArticleId IdType="doi">10.1186/s13023-023-02905-0</ArticleId><ArticleId IdType="pii">10.1186/s13023-023-02905-0</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Lampe C, et al. The impact of COVID-19 on rare metabolic patients and healthcare providers: results from two MetabERN surveys. Orphanet J Rare Dis. 2020;15(1):341. doi: 10.1186/s13023-020-01619-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13023-020-01619-x</ArticleId><ArticleId IdType="pmc">PMC7711270</ArticleId><ArticleId IdType="pubmed">33272301</ArticleId></ArticleIdList></Reference><Reference><Citation>Elmonem MA, et al. The impact of COVID-19 pandemic on the diagnosis and management of inborn errors of metabolism: a global perspective. Mol Genet Metab. 2020;131(3):285&#x2013;8. doi: 10.1016/j.ymgme.2020.09.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ymgme.2020.09.004</ArticleId><ArticleId IdType="pmc">PMC7518833</ArticleId><ArticleId IdType="pubmed">33004274</ArticleId></ArticleIdList></Reference><Reference><Citation>Tard C, et al. Motor and respiratory decline in patients with late onset pompe disease after cessation of enzyme replacement therapy during COVID-19 pandemic. Eur J Neurol. 2022;29(4):1181&#x2013;6. doi: 10.1111/ene.15222.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ene.15222</ArticleId><ArticleId IdType="pubmed">34927321</ArticleId></ArticleIdList></Reference><Reference><Citation>Sechi A, et al. Impact of COVID-19 related healthcare crisis on treatments for patients with lysosomal storage disorders, the first italian experience. Mol Genet Metab. 2020;130(3):170&#x2013;1. doi: 10.1016/j.ymgme.2020.04.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ymgme.2020.04.002</ArticleId><ArticleId IdType="pmc">PMC7189198</ArticleId><ArticleId IdType="pubmed">32386848</ArticleId></ArticleIdList></Reference><Reference><Citation>Limongelli G, et al. Diagnostic issues faced by a rare disease healthcare network during Covid-19 outbreak: data from the Campania Rare Disease Registry. J Public Health (Oxf) 2022;44(3):586&#x2013;94. doi: 10.1093/pubmed/fdab137.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/pubmed/fdab137</ArticleId><ArticleId IdType="pmc">PMC8194710</ArticleId><ArticleId IdType="pubmed">33982102</ArticleId></ArticleIdList></Reference><Reference><Citation>Akar HT, et al. COVID-19-related anxiety in phenylketonuria patients. Turk J Pediatr. 2021;63(5):790&#x2013;800. doi: 10.24953/turkjped.2021.05.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.24953/turkjped.2021.05.007</ArticleId><ArticleId IdType="pubmed">34738361</ArticleId></ArticleIdList></Reference><Reference><Citation>Walkowiak D et al. The impact of the First 2020 COVID-19 Lockdown on the metabolic control of patients with Phenylketonuria. Nutrients, 2021. 13(6).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8231121</ArticleId><ArticleId IdType="pubmed">34204602</ArticleId></ArticleIdList></Reference><Reference><Citation>Paneghetti L, et al. One year of COVID-19: infection rates and symptoms in patients with inherited metabolic diseases followed by MetabERN. Orphanet J Rare Dis. 2022;17(1):109. doi: 10.1186/s13023-022-02247-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13023-022-02247-3</ArticleId><ArticleId IdType="pmc">PMC8894822</ArticleId><ArticleId IdType="pubmed">35246188</ArticleId></ArticleIdList></Reference><Reference><Citation>Altassan R, et al. COVID-19 in unvaccinated patients with inherited metabolic disorders: a single center experience. Eur J Med Genet. 2022;65(11):104602. doi: 10.1016/j.ejmg.2022.104602.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejmg.2022.104602</ArticleId><ArticleId IdType="pmc">PMC9424117</ArticleId><ArticleId IdType="pubmed">36049607</ArticleId></ArticleIdList></Reference><Reference><Citation>Ismailova G, et al. Mild disease course of SARS-CoV-2 infections and mild side effects of vaccination in pompe disease: a cohort description. Orphanet J Rare Dis. 2022;17(1):102. doi: 10.1186/s13023-022-02268-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13023-022-02268-y</ArticleId><ArticleId IdType="pmc">PMC8894826</ArticleId><ArticleId IdType="pubmed">35246221</ArticleId></ArticleIdList></Reference><Reference><Citation>Sandilands K, Williams A, Rylands AJ. Carer burden in rare inherited diseases: a literature review and conceptual model. Orphanet J Rare Dis. 2022;17(1):428. doi: 10.1186/s13023-022-02561-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13023-022-02561-w</ArticleId><ArticleId IdType="pmc">PMC9733280</ArticleId><ArticleId IdType="pubmed">36494728</ArticleId></ArticleIdList></Reference><Reference><Citation>Estrov Y, Scaglia F, Bodamer OA. Psychiatric symptoms of inherited metabolic disease. J Inherit Metab Dis. 2000;23(1):2&#x2013;6. doi: 10.1023/A:1005685010766.</Citation><ArticleIdList><ArticleId IdType="doi">10.1023/A:1005685010766</ArticleId><ArticleId IdType="pubmed">10682302</ArticleId></ArticleIdList></Reference><Reference><Citation>Bonati M, Campi R, Segre G. Psychological impact of the quarantine during the COVID-19 pandemic on the general european adult population: a systematic review of the evidence. Epidemiol Psychiatr Sci. 2022;31:e27. doi: 10.1017/S2045796022000051.</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S2045796022000051</ArticleId><ArticleId IdType="pmc">PMC9069583</ArticleId><ArticleId IdType="pubmed">35475479</ArticleId></ArticleIdList></Reference><Reference><Citation>Fan X et al. The effects of obesity and metabolic abnormalities on severe COVID-19-related outcomes after vaccination: a population-based study. Cell Metab, 2023.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9974355</ArticleId><ArticleId IdType="pubmed">36931274</ArticleId></ArticleIdList></Reference><Reference><Citation>Mutze U et al. Impact of the SARS-CoV-2 pandemic on the health of individuals with intoxication-type metabolic diseases - data from the E-IMD consortium. J Inherit Metab Dis, 2022.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9874390</ArticleId><ArticleId IdType="pubmed">36266255</ArticleId></ArticleIdList></Reference><Reference><Citation>Hall VJ, et al. COVID-19 vaccine coverage in health-care workers in England and effectiveness of BNT162b2 mRNA vaccine against infection (SIREN): a prospective, multicentre, cohort study. Lancet. 2021;397(10286):1725&#x2013;35. doi: 10.1016/S0140-6736(21)00790-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(21)00790-X</ArticleId><ArticleId IdType="pmc">PMC8064668</ArticleId><ArticleId IdType="pubmed">33901423</ArticleId></ArticleIdList></Reference><Reference><Citation>Tummolo A et al. COVID-19 Vaccine in Inherited Metabolic Disorders Patients: A Cross-Sectional Study on Rate of Acceptance, Safety Profile and Effect on Disease Int J Environ Res Public Health, 2022. 19(19).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9566545</ArticleId><ArticleId IdType="pubmed">36231528</ArticleId></ArticleIdList></Reference><Reference><Citation>Rasmussen CDN, Holtermann A, Jorgensen MB. Recall Bias in Low Back Pain among Workers: Effects of Recall Period and Individual and work-related factors. Spine (Phila Pa 1976) 2018;43(12):E727&#x2013;33. doi: 10.1097/BRS.0000000000002457.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/BRS.0000000000002457</ArticleId><ArticleId IdType="pmc">PMC5991172</ArticleId><ArticleId IdType="pubmed">29049088</ArticleId></ArticleIdList></Reference><Reference><Citation>Nagpal K, et al. Who do phone surveys miss, and how to reduce exclusion: recommendations from phone surveys in nine indian states. BMJ Global Health. 2021;6(Suppl 5):e005610. doi: 10.1136/bmjgh-2021-005610.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjgh-2021-005610</ArticleId><ArticleId IdType="pmc">PMC8359516</ArticleId><ArticleId IdType="pubmed">34380709</ArticleId></ArticleIdList></Reference><Reference><Citation>Novick G. Is there a bias against telephone interviews in qualitative research? Res Nurs Health. 2008;31(4):391&#x2013;8. doi: 10.1002/nur.20259.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/nur.20259</ArticleId><ArticleId IdType="pmc">PMC3238794</ArticleId><ArticleId IdType="pubmed">18203128</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>